• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

1991 Fiscal Year Final Research Report Summary

A Study of Major Histocompatibility Antigen Complex (MHC) and Infiltrating Lymphocytes in Uterine Cervical Cancer

Research Project

Project/Area Number 01570943
Research Category

Grant-in-Aid for General Scientific Research (C)

Allocation TypeSingle-year Grants
Research Field Obstetrics and gynecology
Research InstitutionOsaka Medical College

Principal Investigator

SUGIMOTO Osamu  Osaka Medical College, Obstet. and Gynecol., Professor, 医学部, 教授 (00084822)

Co-Investigator(Kenkyū-buntansha) OKAMOTO Yoshiaki  Osaka Medical College, Obstet, and Gynecol., Assistant, 医学部, 助手 (00224080)
OKAMURA Shinsuke  Osaka Medical College, Obstet, and Gynecol., Lecturer, 医学部, 講師 (90104306)
UEKI Minoru  Osaka Medical College, Obstet, and Gynecol., Assistant Professor, 医学部, 助教授 (40084892)
Project Period (FY) 1989 – 1991
KeywordsUterine cervical cancer / Class I antigens / Class II antigens / Lymphocyte / Lymphokines / C-myc oncogene / ICAM-1 / Immunotherapy
Research Abstract

1. We studied on immunological response in cervical cancer at the point of the Major Histocompatibility Complex (MHC) and subsets of the infiltrating lymphocytes, and we found that Class I antigens were missed on cancer cells in some cases, and in such cases CD8+ T cell were less in surrounding the cancer nests. On the other hands, Class II antigens newly expressed in some cases, and in such cases CD4+ lymphocytes were much in surrounding the cancer nests, and CD8+ lymphocytes were detected as the Tumor Infiltrating Lymphocyte (TIL). From this point of view, we suspected that preservation of the Class I antigens and newly expression of the Class II antigens on cervical cancer cells markedly increase the local immune response in cervical cancer. Also IFN-gamma and TNF-alpha progressed the Class I antigens and Class II antigens in vitro experiments, so it was concluded that MHC antigens would be activated with some lymphokines.
2. The c-myc oncogene was amplified and played an important role of oncogenesis in cervical cancer, but that was not correlated with MHC.
3. intercellular adhesion molecule-1 (ICAM-1) is necessary to the interaction between the lymphocytes and the cancer cells. ICAN-1 was detected on some cervical cancer cells and stromal cells. In such cases, lymphocytes were much in surrounding the cancer nests, but ICAM-1 was thought not to be correlated with MHC. ICAM-1 on cancer cells were increased with lymphokines (IFN-gamma, TNF-alpha), so we suggested that we could use lymphokines in immunotherapy to cervical cancer.

  • Research Products

    (8 results)

All Other

All Publications (8 results)

  • [Publications] 植木 実ほか: "子宮頸・体癌の転移陽性例における病態と治療" 産科と婦人科. 56. 1856-1868 (1989)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 岡本 吉明: "子宮頸癌病巣局所免疫応答に関する免疫組織学的研究" 日本産科婦人科学会雑誌. 42. 456-462 (1990)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 植田 政嗣ほか: "婦人科癌培養細胞におけるcーmyc遺伝子産物の発現とその解析" 日本産科婦人科学会雑誌. 43. 1489-1495 (1991)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 岡本 吉明ほか: "子宮頸癌:低分化勧の特性" KARKINOS. 4. 203-207 (1991)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Minoru UEKI et. al: "Clinicopathological Feature and Therapy in Cervical Cancer and Endometrial Cancer those have Lymphnode Metastasis" Obstet, Gynecol. <tokyo>.56. 1856-1868 (1989)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Yoshiaki OKAMOTO: "An Immunohistochemical Study on Regional Immunological Response of Uterine Cervical Cancer" Acta Obst Gynaec Jpn.42. 456-462 (1990)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Masatsugu UEDA et. al: "In vitro Studies on the Expression of c-myc Oncogene Product in Gynecological Cultured Cancer Cells" Acta Obst Gynaec Jpn.43. 1489-1495 (1991)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Yoshiaki OKAMOTO et. al: "Cervical Cancer" KARKINOS. 4. 203-207 (1991)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 1993-03-16  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi